{"id":59349,"date":"2026-09-16T12:41:23","date_gmt":"2026-09-16T10:41:23","guid":{"rendered":"https:\/\/editing.capitalmind.com\/?post_type=deals&#038;p=59349"},"modified":"2026-09-22T17:52:31","modified_gmt":"2026-09-22T15:52:31","slug":"cession-de-deux-centres-ophtalmologiques-a-sanoptis","status":"publish","type":"deals","link":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","title":{"rendered":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A propos du deal<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Investec a conseill\u00e9 les deux actionnaires des centres ophtalmologiques suisses Augenzentrum Interlaken et Augenzentrum Frutigen dans le cadre de leur cession \u00e0 Sanoptis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ces deux soci\u00e9t\u00e9s soeurs proposent une offre compl\u00e8te de soins ophtalmologiques m\u00e9dicaux et chirurgicaux, y compris des traitements programm\u00e9s. Leur \u00e9quipe, compos\u00e9e de trois m\u00e9decins et d\u2019environ 15 collaborateurs, prend en charge plus de 10 000 patients et r\u00e9alise pr\u00e8s de 1 000 interventions chirurgicales par an.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sanoptis est un groupe europ\u00e9en de premier plan sp\u00e9cialis\u00e9 en ophtalmologie. Bas\u00e9 en Suisse, le groupe est pr\u00e9sent dans six pays europ\u00e9ens. Il compte plus de 5 000 collaborateurs et environ 1 000 m\u00e9decins r\u00e9partis sur pr\u00e8s de 500 sites, et r\u00e9alise chaque ann\u00e9e 4 millions de traitements chirurgicaux et m\u00e9dicaux.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Notre r\u00f4le<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">L&rsquo;\u00e9quipe d&rsquo;Investec a conseill\u00e9 les actionnaires tout au long du processus de cession, notamment :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pr\u00e9paration du <em>business plan<\/em> et des supports marketing<\/li>\n\n\n\n<li>Identification d\u2019acqu\u00e9reurs strat\u00e9giques et financiers potentiels<\/li>\n\n\n\n<li>Mise en \u0153uvre d\u2019un processus de vente concurrentiel<\/li>\n\n\n\n<li>Pr\u00e9paration et gestion de la <em>due diligence<\/em><\/li>\n\n\n\n<li>Conduite des n\u00e9gociations finales<\/li>\n\n\n\n<li>Coordination de toutes les parties prenantes, en ce compris les conseils juridiques et fiscaux<\/li>\n<\/ul>\n\n\n<section class=\"content--block quoteBlock \">\n    <div class=\"holder\">\n        <div class=\"stories slide-up d-flex\" data-scroll=\"\">\n            \n            <blockquote class=\"stories__desc\" style=\"flex: 0 0 100%;max-width: 100%;\">\n                <span class=\"stories__desc_quote\">\u201c\u201d<\/span>\n\n                                    <div class=\"justified\"><p>Nous sommes ravi de l&rsquo;accompagnement de l&rsquo;\u00e9quipe d&rsquo;Investec qui nous a non seulement apport\u00e9 son expertise dans la recherche du partenaire id\u00e9al pour nos centres, mais qui nous a \u00e9galement accompagn\u00e9s avec assurance et pragmatisme tout au long du processus, y compris dans les situations les plus d\u00e9licates.<\/p>\n<p>Gr\u00e2ce \u00e0 l\u2019expertise, l\u2019engagement et l\u2019approche tr\u00e8s orient\u00e9e r\u00e9sultats d\u2019Investec, nous avons pu concr\u00e9tiser une transaction avec un partenaire \u00e0 la fois en ad\u00e9quation avec nos valeurs et pertinent sur le plan strat\u00e9gique.<\/p>\n<p>Nous avons particuli\u00e8rement appr\u00e9ci\u00e9 le soutien d\u2019Investec et la qualit\u00e9 de la collaboration avec l\u2019\u00e9quipe tout au long de la transaction. Cette exp\u00e9rience nous a pleinement confort\u00e9s dans notre choix d\u2019Investec comme conseil.<\/p>\n<\/div>                \n\n                                    <cite>&#8211; Dr Andreas Wild, fondateur et actionnaire, Augenzentrum Interlaken \/ Augenzentrum Frutigen<\/cite>\n                            <\/blockquote>\n        <\/div><!-- \/.stories -->\n    <\/div>\n<\/section>\n<!-- ============= End of \/.QuoteBlock =============== -->","protected":false},"excerpt":{"rendered":"<p>Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis&#8230;.<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3768],"dealtype":[3706],"clienttype":[3729],"class_list":["post-59349","deals","type-deals","status-publish","hentry","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory\" \/>\n<meta property=\"og:description\" content=\"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-22T15:52:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\",\"name\":\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\"},\"datePublished\":\"2026-09-16T10:41:23+00:00\",\"dateModified\":\"2026-09-22T15:52:31+00:00\",\"description\":\"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capitalmind---corporate-finance-advisory\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","description":"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","og_locale":"fr_FR","og_type":"article","og_title":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","og_description":"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis","og_url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","og_site_name":"Investec Business Advisory","article_modified_time":"2026-09-22T15:52:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","name":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","isPartOf":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#website"},"datePublished":"2026-09-16T10:41:23+00:00","dateModified":"2026-09-22T15:52:31+00:00","description":"Investec a conseill\u00e9 les actionnaires des centres ophtalmologiques Interlaken et Frutigen dans le cadre de leur adossement au groupe Sanoptis","breadcrumb":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.investec.com\/advisory\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis"}]},{"@type":"WebSite","@id":"https:\/\/www.investec.com\/advisory\/fr\/#website","url":"https:\/\/www.investec.com\/advisory\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investec.com\/advisory\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/www.investec.com\/advisory\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals\/59349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/media?parent=59349"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dt?post=59349"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/sector?post=59349"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dealtype?post=59349"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/clienttype?post=59349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}